Literature DB >> 34656972

Response to: Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Yalta et al.

Shruti S Joshi1, Trisha Singh2, Jagdeep Singh3, David E Newby2.   

Abstract

Entities:  

Keywords:  diabetes mellitus; heart failure

Mesh：

Substances：

Year:  2021        PMID： 34656972     DOI： 10.1136/heartjnl-2021-320174

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

Review 1.  Prevention of Cardiorenal Complications with Sodium-Glucose Cotransporter Type 2 Inhibitors: A Narrative Review.

Authors:  Manuel Botana; Javier Escalada; Ángel Merchante; Rebeca Reyes; Pedro Rozas
Journal:  Diabetes Ther       Date:  2022-06-15       Impact factor: 3.595

2.  ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.

Authors:  Stefania Angela Di Fusco; Edoardo Gronda; Edoardo Mocini; Fabiana Lucà; Irma Bisceglia; Leonardo De Luca; Pasquale Caldarola; Manlio Cipriani; Marco Corda; Alfredo De Nardo; Giuseppina Maura Francese; Cosimo Napoletano; Alessandro Navazio; Carmine Riccio; Loris Roncon; Emanuele Tizzani; Federico Nardi; Stefano Urbinati; Serafina Valente; Michele Massimo Gulizia; Domenico Gabrielli; Fabrizio Oliva; Giuseppe Imperoli; Furio Colivicchi
Journal:  Eur Heart J Suppl       Date:  2022-05-18       Impact factor: 1.624

3.  Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Hufang Zhou; Wenhua Peng; Fuyao Li; Yuelin Wang; Baofu Wang; Yukun Ding; Qian Lin; Ying Zhao; Guozhong Pan; Xian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-04

4.  An Experimental Design Approach to Quantitative Expression for Quality Control of a Multicomponent Antidiabetic Formulation by the HILIC Method.

Authors:  Mahesh Attimarad; Katharigatta Narayanaswamy Venugopala; Muhammad S Chohan; Marysheela David; Efren Ii Plaza Molina; Nagaraja Sreeharsha; Anroop Balachandran Nair; Christophe Tratrat; Abdulrahman Ibrahim Altaysan; Abdulmalek Ahmed Balgoname
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

5.  Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus.

Authors:  Camila Moreno Rosa; Dijon Henrique Salome Campos; David Rafael Abreu Reyes; Felipe Cesar Damatto; Lucas Yamada Kurosaki; Luana Urbano Pagan; Mariana Janini Gomes; Camila Renata Corrêa; Ana Angelica Henrique Fernandes; Marina Politi Okoshi; Katashi Okoshi
Journal:  Antioxidants (Basel)       Date:  2022-05-17

6.  Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis.

Authors:  Zepeng Shi; Feng Gao; Wei Liu; Xuezhi He
Journal:  Front Cardiovasc Med       Date:  2022-04-04

Review 7.  Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.

Authors:  Peter A McCullough; Alpesh Amin; Kevin M Pantalone; Claudio Ronco
Journal:  J Am Heart Assoc       Date:  2022-05-26       Impact factor: 6.106

8.  Acetazolamide for patients with acute decompensated heart failure with volume overload.

Authors:  Xavier Rossello; Venu Menon; Pascal Vranckx
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.